PharMerica CORP Form 8-K: Current report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2011-11-04: Form 8-K; Period of report 2011-11-03; Description 2.02 Results of Operations and Financial Condition.
- 2011-10-31: Form 8-K/A; Period of report 2011-06-10; Description 5.07 Submission of Matters to a Vote of Security Holders; Details 5.07.
- 2011-09-22: Form 8-K; Period of report 2011-09-18; Description 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; Details 5.02.
- 2011-08-25: Form 8-K; Period of report 2011-08-25; Description 1.01 Entry into a Material Definitive Agreement; 3.03 Material Modification to Rights of Security Holders; 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; 8.01 Other Events; Details 1.01.
| Filed | Form | Period of report | Description | Details | Document |
|---|---|---|---|---|---|
| 2011-11-04 | 8-K | 2011-11-03 | 2.02 Results of Operations and Financial Condition | a50056417.htm | |
| 2011-10-31 | 8-K/A | 2011-06-10 | 5.07 Submission of Matters to a Vote of Security Holders | 5.07 At the Company’s 2011 Annual Meeting of Shareholders, the Company’s stockholders voted on, among other matters, a non-binding advisory proposal regarding the frequency of future stockholder non-binding advisory votes on the compensation of the Company’s named executive officers (“Say-on-Pay Votes”). | d248553d8ka.htm |
| 2011-09-22 | 8-K | 2011-09-18 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On September 18, 2011, PharMerica Corporation (the “Corporation”) entered into indemnification agreements with each of its directors and executive officers. | d235672d8k.htm |
| 2011-08-25 | 8-K | 2011-08-25 | 1.01 Entry into a Material Definitive Agreement; 3.03 Material Modification to Rights of Security Holders; 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; 8.01 Other Events | 1.01 Entry into a Material Definitive Agreement. 3.03 On August 25, 2011, the Board of Directors of PharMerica Corporation (the “Company”), a Delaware corporation, declared a dividend of one preferred share purchase right (a “Right”) for each outstanding share of common stock, par value $0.01 per share (the “Common Stock”). 5.03 In connection with the adoption of the Rights Agreement referenced in Item 3.03 above, the Board of Directors approved the Certificate of Designation establishing the Preferred Stock and the rights, preferences and privileges thereof. 8.01 On August 25, 2011, the Board of Directors determined that any Distribution Date that would otherwise result under Section 3(a)(ii) of the Rights Agreement from the public announcements and actions of Omnicare, Inc. and any affiliate thereof be deferred until such time, if ever, that the Board of Directors determines to eliminate such deferral. | d8k.htm |
| 2011-08-04 | 8-K | 2011-08-04 | 2.02 Results of Operations and Financial Condition | a6819800.htm | |
| 2011-06-14 | 8-K | 2011-06-10 | 5.07 Submission of Matters to a Vote of Security Holders; 7.01 Regulation FD Disclosure | 5.07 The 2011 Annual Meeting of Stockholders of the Company was held on June 10, 2011. 7.01 On June 13, 2011, the Company issued a press release announcing the results of the Annual Meeting of the Stockholders held on June 10, 2011. | d8k.htm |
| 2011-05-04 | 8-K | 2011-05-04 | 2.02 Results of Operations and Financial Condition | a6709975.htm | |
| 2011-03-31 | 8-K | 2011-03-25 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On March 25, 2011, the Board of Directors of PharMerica Corporation (the “Corporation”), upon recommendation of the Compensation Committee, adopted the 2011 Short-Term Incentive Program (the “CEO STIP”) under the PharMerica Corporation 2007 Omnibus Incentive Plan, as amended (the “Omnibus Plan”), for the Corporation’s Chief Executive Officer, Mr. Gregory Weishar. | d8k.htm |
| 2011-03-31 | 8-K | 2011-03-01 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On March 1, 2011, the Board of Directors of PharMerica Corporation (the “Corporation”) granted awards of Restricted Stock Units (“RSUs”) under the PharMerica Corporation 2007 Omnibus Incentive Plan, as amended (the “Omnibus Plan”) to the Corporation’s named executive officers as set forth below as an additional incentive and retention component to the recipients’ compensation packages. | d8k.htm |
| 2011-02-24 | 8-K | 2011-02-24 | 2.02 Results of Operations and Financial Condition | a6625297.htm | |
| 2011-01-20 | 8-K/A | 2010-11-04 | 2.01 Completion of Acquisition or Disposition of Assets | 2.01 This Current Report on Form 8-K/A amends the Current Report on Form 8-K filed with the Securities and Exchange Commission on November 10, 2010 by PharMerica Corporation, a Delaware corporation (the “Company”), to provide the required financial statements and exhibits in connection with the Company’s acquisition through a wholly-owned subsidiary, of substantially all of the assets of Chem Rx Corporation and certain of its wholly-owned subsidiaries (collectively, the “Seller”) for $70.6 million in cash plus the assumption of specified liabilities related to the assets, pursuant to Section 363 of the United States Bankruptcy Code. | d8ka.htm |
| 2011-01-10 | 8-K | 2011-01-04 | 1.01 Entry into a Material Definitive Agreement | 1.01 On January 4, 2011, PharMerica Corporation (the “Corporation”) entered into an Amended and Restated Prime Vendor Agreement for Long-Term Care Pharmacies by and between AmerisourceBergen Drug Corporation (“ABDC”), the Corporation, Pharmacy Corporation of America and Chem Rx Pharmacy Services, LLC (the “Amended Agreement”). | d8k.htm |